The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev ... The most common ones include skin reactions where the injection ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system ... 2024 — Certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies ...

Common Degenerative Brain Disease May Begin to Develop in Middle ... In the future, the discovery may be used in treatment for Parkinson's ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

"For too long, the Parkinson's community has had limited treatment options for advanced disease," Robert Hauser ... and mild or moderate. The most common adverse reactions with an incidence ...